NO20031995D0 - Fremgangsmåte - Google Patents

Fremgangsmåte

Info

Publication number
NO20031995D0
NO20031995D0 NO20031995A NO20031995A NO20031995D0 NO 20031995 D0 NO20031995 D0 NO 20031995D0 NO 20031995 A NO20031995 A NO 20031995A NO 20031995 A NO20031995 A NO 20031995A NO 20031995 D0 NO20031995 D0 NO 20031995D0
Authority
NO
Norway
Prior art keywords
compounds
ammonium
approach
azasteroids
steriods
Prior art date
Application number
NO20031995A
Other languages
English (en)
Other versions
NO20031995L (no
NO325180B1 (no
Inventor
Roman Davis
Alan Millar
Thomas Jeffrey Sterbenz
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20031995D0 publication Critical patent/NO20031995D0/no
Publication of NO20031995L publication Critical patent/NO20031995L/no
Publication of NO325180B1 publication Critical patent/NO325180B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Valve Device For Special Equipments (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20031995A 2000-11-03 2003-05-02 Fremgangsmate for fremstilling av 3-okso-4-azasteroid og anvendelse derav NO325180B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0026876.3A GB0026876D0 (en) 2000-11-03 2000-11-03 Process
PCT/US2001/048173 WO2002046207A2 (en) 2000-11-03 2001-11-02 Process

Publications (3)

Publication Number Publication Date
NO20031995D0 true NO20031995D0 (no) 2003-05-02
NO20031995L NO20031995L (no) 2003-05-02
NO325180B1 NO325180B1 (no) 2008-02-11

Family

ID=9902484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031995A NO325180B1 (no) 2000-11-03 2003-05-02 Fremgangsmate for fremstilling av 3-okso-4-azasteroid og anvendelse derav

Country Status (24)

Country Link
US (1) US6794508B2 (no)
EP (1) EP1335930B1 (no)
JP (1) JP4257117B2 (no)
KR (1) KR100821018B1 (no)
CN (1) CN1313480C (no)
AT (1) ATE279429T1 (no)
AU (2) AU2002241624B2 (no)
BR (1) BR0115089A (no)
CA (1) CA2427709A1 (no)
DE (1) DE60106482T2 (no)
DK (1) DK1335930T3 (no)
ES (1) ES2230383T3 (no)
GB (1) GB0026876D0 (no)
HK (1) HK1058799A1 (no)
HU (1) HUP0303907A3 (no)
IL (2) IL155078A0 (no)
MX (1) MXPA03003925A (no)
NO (1) NO325180B1 (no)
NZ (1) NZ525168A (no)
PL (1) PL206539B1 (no)
PT (1) PT1335930E (no)
SI (1) SI1335930T1 (no)
WO (1) WO2002046207A2 (no)
ZA (1) ZA200302560B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503193B1 (ko) 2002-08-19 2005-07-25 한미약품 주식회사 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
WO2005075497A1 (en) * 2004-01-07 2005-08-18 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF 17ß-SUBSTITUTED-3-OXO-4-AZA-5ALPHA-ANDROSTANE DERIVATIVES
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
AR070313A1 (es) * 2008-01-03 2010-03-31 Gador Sa Un procedimiento para preparar una forma solida y cristalina de dutasteride, una forma polimorfica del compuesto (forma iii) y una composicion farmaceutica que incluye dicha forma
HU230730B1 (hu) 2011-06-30 2017-12-28 Richter Gedeon Nyrt Eljárás (5alfa,17béta)-N-[2,5-bisz-(trifluormetil)-fenil]-3-oxo-4-aza-5-androszt-1-én-17-karbonsavamid előállítására
CN103059097A (zh) * 2011-10-20 2013-04-24 连云港润众制药有限公司 一种度他雄胺中间体的制备方法
CN103254268A (zh) * 2013-05-16 2013-08-21 寿光市富康化学工业有限公司 一种制备度他雄胺的工艺
CN104231033B (zh) * 2014-09-17 2016-08-24 广东众生药业股份有限公司 一种度他雄胺的制备方法
CN108051513B (zh) * 2017-11-27 2020-09-29 重庆华邦制药有限公司 Hplc法分离测定度他雄胺起始原料sm2及其相关杂质的方法
CN109438549B (zh) * 2018-12-13 2022-01-04 湖北葛店人福药业有限责任公司 一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211145A (en) 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB2264494A (en) * 1992-02-25 1993-09-01 Merck & Co Inc 17b-n-monosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-1-en-3-one testosterone-5-alpha reductase inhibitors
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones

Also Published As

Publication number Publication date
DE60106482D1 (de) 2004-11-18
CN1313480C (zh) 2007-05-02
BR0115089A (pt) 2003-10-07
ATE279429T1 (de) 2004-10-15
ZA200302560B (en) 2004-04-01
NZ525168A (en) 2005-03-24
EP1335930A2 (en) 2003-08-20
CA2427709A1 (en) 2002-06-13
NO20031995L (no) 2003-05-02
PL365705A1 (en) 2005-01-10
DE60106482T2 (de) 2005-10-13
SI1335930T1 (en) 2005-04-30
ES2230383T3 (es) 2005-05-01
HUP0303907A3 (en) 2012-09-28
GB0026876D0 (en) 2000-12-20
DK1335930T3 (da) 2005-02-14
US20040049042A1 (en) 2004-03-11
IL155078A (en) 2009-06-15
WO2002046207A3 (en) 2003-03-20
JP4257117B2 (ja) 2009-04-22
KR100821018B1 (ko) 2008-04-08
EP1335930B1 (en) 2004-10-13
IL155078A0 (en) 2003-10-31
JP2004515505A (ja) 2004-05-27
NO325180B1 (no) 2008-02-11
MXPA03003925A (es) 2003-08-19
HK1058799A1 (en) 2004-06-04
PT1335930E (pt) 2005-01-31
KR20030081326A (ko) 2003-10-17
AU4162402A (en) 2002-06-18
PL206539B1 (pl) 2010-08-31
AU2002241624B2 (en) 2004-10-28
HUP0303907A2 (hu) 2004-03-01
US6794508B2 (en) 2004-09-21
CN1473165A (zh) 2004-02-04
WO2002046207A2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
BRPI0113670B8 (pt) composição farmacêutica e método para tratar hipogonadismo
ATE255589T1 (de) Kristallin form i von clarithromycin
DE69828958D1 (de) Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
PT1196414E (pt) Pro-farmacos de inibidores carbamato de impdh
NO20031995D0 (no) Fremgangsmåte
DE60204322D1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
ATE363280T1 (de) Verwendung von pioglitazone zur verbesserung der ketose und der azidose
ES2243579T3 (es) Derivados de pirazolopirideno.
DE60021113D1 (de) Albumin-bindende verbindungen die die nichtenzymatische glycosylierung verhindern und die zur behandlung von glycosylierungsbedingten erkrankungen verwendet werden können
DE60001850D1 (de) Chalcon coumarine
EE05318B1 (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hpogonadismi raviks
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
AU2001231849A1 (en) Use of dehydroepiandrosterone and/or precursors or derivatives thereof to improve papery aspect of the skin
BR0115416A (pt) Método para a preparação de uma composição catalisadora e seu uso em um processo de polimerização
DE60002692D1 (de) Leberspezifische gallensaeurederivate des antiglukokorticoids ru486
DE60220699D1 (de) Tibolonformulierungen
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
DE50112512D1 (de) Phenanthridinderivate und phenanthridin enthaltende antitumorale arzneimittel
GB957541A (en) 5ª‡-steroids
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка
ECSP003326A (es) 1,2,3,4,5,6 - hexahidro- 2,6 - metano - 3 - benzazocin - 10 - oles sustituidos con n- (5- fenil- tetahidrofuranil) metilo y n-(6-feniltetrahidropiranil) metilo; procedimientos para prepararlos y su empleo como composiciones farmaceuticas
CR8736A (es) D-homo-17-cloro-16(17)eno esteroides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees